Based on the above results, we ask the following question: in gene therapy of PCD patients with ODAD1 mutations, do dysfunctional endogenous mutant proteins inhibit the function of exogenous wild-type proteins? Here, ODAD1 is linked to primary ciliary dyskinesia.